Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy

Tumor initiating stem cells (TISCs) are a subset of tumor cells, which are implicated in cancer relapse and resistance to chemotherapy. The metabolic programs that drive TISC functions are exquisitely unique and finely-tuned by various oncogene-driven transcription factors to facilitate pro-cancerou...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandekar, Durga, Amara, Suneetha, Tiriveedhi, Venkataswarup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494937/
https://www.ncbi.nlm.nih.gov/pubmed/31106150
http://dx.doi.org/10.3389/fonc.2019.00315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494937/
https://www.ncbi.nlm.nih.gov/pubmed/31106150
http://dx.doi.org/10.3389/fonc.2019.00315

Ejemplares similares